InMode (INMD) Research & Development (2018 - 2026)
InMode (INMD) posted quarterly Research & Development of $42.9 million for Q1 2026, up 8.07% year-on-year from $39.7 million in Q1 2025, and down 11.31% on a QoQ basis from $48.4 million in Q4 2025.
InMode (INMD) Research & Development (2018 - 2026) Analysis & Trends
InMode (INMD) has reported Research & Development for 9 consecutive years, with $42.9 million the latest figure, recorded in Q1 2026.
- Quarterly Research & Development rose 8.07% year-over-year to $42.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $183.8 million (up 1.37% YoY) and the FY2025 annual result came in at $180.6 million, changed 0.43% from the prior year.
- Research & Development eased to $42.9 million in Q1 2026 per INMD's latest filing, from $48.4 million in the prior quarter.
- Over the last five years, Research & Development for INMD reached as high as $51.9 million in Q3 2024 and fell as low as $30.8 million in Q1 2022.
- A 5-year average of $44.6 million and a median of $45.0 million in 2025 frame the typical range for Research & Development.
- Annual changes were most pronounced in 2022 — Research & Development soared 39.65% — and 2025, when it declined 13.29%.
- Year by year, Research & Development stood at $47.0 million in 2022, then gained by 5.19% to $49.5 million in 2023, then retreated by 9.7% to $44.7 million in 2024, then climbed by 8.41% to $48.4 million in 2025, then declined by 11.31% to $42.9 million in 2026.
- According to Business Quant data, Research & Development over the past three periods registered $42.9 million, $48.4 million, and $45.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 767.00 Mn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 413.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 671.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 516.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 263.30 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 145.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | -461.27 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 345.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | InMode | 956,721.10 | -479.17 Mn | 61.55 Mn | 42.93 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 42.93 Mn |
| Dec 31, 2025 | 48.41 Mn |
| Sep 30, 2025 | 44.97 Mn |
| Jun 30, 2025 | 47.47 Mn |
| Mar 31, 2025 | 39.73 Mn |
| Dec 31, 2024 | 44.65 Mn |
| Sep 30, 2024 | 51.86 Mn |
| Jun 30, 2024 | 45.06 Mn |
| Mar 31, 2024 | 39.80 Mn |
| Dec 31, 2023 | 49.45 Mn |
| Sep 30, 2023 | 50.82 Mn |
| Jun 30, 2023 | 51.06 Mn |
| Mar 31, 2023 | 41.71 Mn |
| Dec 31, 2022 | 47.01 Mn |
| Sep 30, 2022 | 43.06 Mn |
| Jun 30, 2022 | 39.65 Mn |
| Mar 31, 2022 | 30.85 Mn |
| Dec 31, 2021 | 35.29 Mn |
| Sep 30, 2021 | 30.84 Mn |
| Jun 30, 2021 | 28.67 Mn |